🚀 Laurus Labs: Momentum Backed by Strong Fundamentals!

: Laurus Labs has witnessed a sharp upmove after delivering stellar Q1 FY26 results. With improving margins, strong CDMO traction, and high investor interest, the stock is now trending firmly upward. Here’s a breakdown of the technical and fundamental outlook: 🔹 Short-Term View (2–4 Weeks) Stock rallied over 6% post-results with strong volumes RSI above 80 indicates overbought zone — possible minor pullback Key resistance near ₹905–920; support at ₹860 and ₹835 Positive momentum intact as long as ₹860 holds 🟢 Strategy: Wait for breakout above ₹920 or buy on dip toward ₹860–₹870 with SL ₹820 🔹 Long-Term View (6–12 Months) Revenue: ₹1,570 Cr (↑31% YoY) EBITDA: ₹389 Cr (↑127% YoY) | Margins expanded to 24.8% PAT: ₹163 Cr (↑1,154% YoY) — driven by CDMO and formulation growth ARV and Custom Synthesis segments seeing strong demand Management confident of FY26 growth visibility 🟢 Strategy: Accumulate on dips for long-term targets of ₹1,050–₹1,100 with SL ₹770